Lv1
40 积分 2022-08-30 加入
Immunotherapy in acute myeloid leukemia: The antibodies, TriKEs, and CARs on the arduous road to cure
17天前
已完结
Overexpression of FZD7 is associated with poor survival in patients with colon cancer
1个月前
已完结
YTHDF1-mediated m6A modification promotes cisplatin resistance in ovarian cancer via the FZD7/Wnt/β-catenin pathway
1个月前
已完结
Frizzled Receptors in Development and Disease
1个月前
已完结
Izalontamab brengitecan (Iza-bren; BL-B01D1), a first-in-class EGFR-HER3 bispecific antibody–drug conjugate, for patients with EGFR-mutated NSCLC: pooled analysis of phase I and phase II trials
1个月前
已完结
Harnessing the CD2 axis to broaden and enhance the efficacy of CAR T-cell therapies
3个月前
已完结
BCMA-Targeted T-Cell Engager for Autoimmune Hemolytic Anemia after CD19 CAR T-Cell Therapy
3个月前
已完结
Targeting the Stromal-Immune Barrier: A Novel Strategy to Overcome Resistance to CLDN18.2/CD3 Bispecific T-Cell Engager Therapy in Pancreatic Cancer
3个月前
已关闭
Identification and analysis of NAC genes related to S-alk(en)yl cysteine sulfoxides (CSOs) biosynthesis in Onion (Allium cepa L.)
4个月前
已完结
The storm has cleared: lessons from the CD28 superagonist TGN1412 trial
5个月前
已完结
皖公网安备34019202002308
